Multicenter tract-based analysis of microstructural lesions within the Alzheimer’s disease spectrum: association with amyloid pathology and diagnostic usefulness

Manuscript Number: 

19-0446R1

Author(s): 
Claudia Bartels, Frederic Brosseron, Martina Buchmann, Katharina Buerger, Cihan Catak, Peter Dechent, Laura Dobisch, Martin Dyrba, Emrah Düzel, Birgit Ertl-Wagner, Klaus Fliessbach, John-Dylan Haynes, Michael T. Heneka, Daniel Janowitz, Frank Jessen, Ingo Kilimann, Jan O. Kuper-Smith, Christoph Laske, Siyao Li, Felix Menne, Coraline Metzger, Josef Priller, Verena Pross, Alfredo Ramirez, Klaus Scheffler, Anja Schneider, Annika Spottke, Eike J. Spruth, Stefan J. Teipel, Michael Wagner, Jens Wiltfang, Steffen Wolfsgruber

Disclosures

Claudia Bartels

  • Nothing to Disclose

Frederic Brosseron

  • Nothing to Disclose

Martina Buchmann

  • Nothing to Disclose

Katharina Buerger

  • Consulting Fees:
    Single Meeting of the Biogen Germany Advisory Board on Aducanumab

Cihan Catak

  • Nothing to Disclose

Peter Dechent

  • Nothing to Disclose

Laura Dobisch

  • Nothing to Disclose

Emrah Düzel

  • Nothing to Disclose

Martin Dyrba

  • Nothing to Disclose

Birgit Ertl-Wagner

  • Nothing to Disclose

Klaus Fliessbach

  • Nothing to Disclose

John-Dylan Haynes

  • Nothing to Disclose

Michael T. Heneka

  • Consulting Fees:
    Advisory Clinical advisory board: IFM Therapeutics Scientific advisory board: Alector
    Lecture Fees:
    Honoraria for oral presentations from Pfizer, Novartis, Roche, Abbvie and Biogen
    Patents/Royalties
    Research support from Schering, Actelion, Pfizer and Novartis

Daniel Janowitz

  • Nothing to Disclose

Frank Jessen

  • Consulting Fees:
    Advisory fees from: Roche, Biogene, AC Immune, Janssen, GE Healthcare

Ingo Kilimann

  • Nothing to Disclose

Jan O. Kuper-Smith

  • Nothing to Disclose

Christoph Laske

  • Nothing to Disclose

Siyao Li

  • Nothing to Disclose

Felix Menne

  • Nothing to Disclose

Coraline Metzger

  • Nothing to Disclose

Josef Priller

  • Consulting Fees:
    Axon
    Patents/Royalties
    Epomedics (licensed patent)

Verena Pross

  • Nothing to Disclose

Alfredo Ramirez

  • Nothing to Disclose

Klaus Scheffler

  • Nothing to Disclose

Anja Schneider

  • Nothing to Disclose

Annika Spottke

  • Nothing to Disclose

Eike J. Spruth

  • Nothing to Disclose

Stefan J. Teipel

  • Consulting Fees:
    Advisory Board for MSD 2018 (honorary paid to institution) Advisory Board for Roche 2019 (honorary paid to institution)
    Lecture Fees:
    two presentations with MSD 2018

Michael Wagner

  • Nothing to Disclose

Jens Wiltfang

  • Consulting Fees:
    Eli Lilly -Travel costs Hoffmann-La-Roche MSD Sharp + Dome Boehringer-Ingelheim Immungenetics Abbot EPD
    Lecture Fees:
    Med update GmbH twice a year Pfizer honorarium for lectures Janssen-Cilag honorarium for lectures Actelion
    Patents/Royalties
    Patent no.: EP1270592B1; patent no.: US 6,849,416 B2; patent no.: EP2095128B1; patent no.: EP3105589A1
    Grants
    • Agency: 
      Immungenetics AG
      Dates: 
      2017

Steffen Wolfsgruber

  • Nothing to Disclose